The following new grants were awarded to JCCC members, announced in December 2012:

Principal Investigator: Cloughesy, Timothy

Sponsor Name: Tocagen, Inc.

Award Title: Continuation Protocol for Patients Previously Enrolled in a Study of TOCA 511

Principal Investigator: Dubinett, Steven

Sponsor Name: University of California, San Francisco

Award Title: Engaging University of California Stakeholders for Biorepository Research

Principal Investigator: Finn, Richard

Sponsor Name: Novartis Pharmaceuticals (Novartis Ag (Inc.l Pharma,animal Hl

Award Title: In Vivo Evaluation of Pi3k Compounds (Bkm120; byl719) in Combination with Fluvestrant in Models with Acquired Resistance to Rad001

Principal Investigator: Finn, Richard

Sponsor Name: Novartis Pharmaceuticals (Novartis Ag)

Award Title: Interrogation of annotated Tumor Banks for Presence of Specific Genes and/or Molecular Targets Relevant for the JAK/Stat Pathway

Principal Investigator: Martinez-Maza, Otoniel

Sponsor Name: NIH/Center for Scientific Review

Award Title: HIV-Driven B Cell Activation: Role in the Genesis of Aids-Related Lymphoma

Principal Investigator: Sun, Ren

Sponsor Name: California Capital Equity, LLC

Award Title: Systematical Identification of HIV Resistant Mutants to Inhibitors Targeting RRE-Rev Binding

Principal Investigator: Tseng, Hsian-Rong

Sponsor Name: NIH/Center for Scientific Review

Award Title: Supramolecular Nanoparticle-Based Pet Probes for Pretargeted Tumor Imaging